M
Michael Bachmann
Researcher at Helmholtz-Zentrum Dresden-Rossendorf
Publications - 402
Citations - 16252
Michael Bachmann is an academic researcher from Helmholtz-Zentrum Dresden-Rossendorf. The author has contributed to research in topics: Antigen & Chimeric antigen receptor. The author has an hindex of 63, co-authored 360 publications receiving 14388 citations. Previous affiliations of Michael Bachmann include ACADIA Pharmaceuticals Inc. & University of Southern California.
Papers
More filters
Journal ArticleDOI
Multimodal PET/MRI Imaging Results Enable Monitoring the Side Effects of Radiation Therapy
Noémi Kovács,Krisztián Szigeti,Nikolett Hegedűs,Ildiko Horvath,Dániel S. Veres,Michael Bachmann,Ralf Bergmann,Domokos Máthé +7 more
TL;DR: A sensitive multimodal imaging protocol seems to be an appropriate method for follow-up of the health status after radiation therapy and makes possible parallel screening of healthy tissues and the effectiveness of tumor therapy without any additional radiation exposure.
Journal ArticleDOI
18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
Sebastian Zschaeck,Julian Weingärtner,Elia Lombardo,Sebastian Marschner,Marina Hajiyianni,Marcus Beck,Daniel Zips,Yimin Li,Qin Lin,Holger Amthauer,Esther G.C. Troost,Jörg van den Hoff,Volker Budach,Jörg Kotzerke,Konstantinos Ferentinos,Efstratios Karagiannis,David Kaul,Vincent Grégoire,Adrien Holzgreve,Nathalie L. Albert,P Nikulin,Michael Bachmann,Klaus Kopka,Mechthild Krause,Michael H. Baumann,Joanna Kaźmierska,Paulina Cegla,Witold Cholewiński,Iosif Strouthos,Klaus Zöphel,Ewa Majchrzak,Guillaume Landry,Claus Belka,Carmen Stromberger,Frank Hofheinz +34 more
TL;DR: FDG-PET parameters bear considerable prognostic value in HNSCC and potential predictive value in subgroups of patients, especially regarding treatment de-intensification and organ-preservation, and the identified cut-off values should be implemented as benchmark routine imaging parameters.
Proceedings ArticleDOI
Patterning process exploration of metal 1 layer in 7nm node with 3D patterning flow simulations
Weimin Gao,Weimin Gao,Ivan Ciofi,Yves Saad,Philippe Matagne,Michael Bachmann,Mohamed Oulmane,Werner Gillijns,Kevin Lucas,Wolfgang Demmerle,Thomas Schmoeller +10 more
TL;DR: In this paper, a simulation tool that enables emulation of the whole patterning flow with realistic process-dependent 3D profile and topology has been proposed to study the patterning process variations of N7 M1 layer including the overlay control, the critical dimension uniformity (CDU) budget and the lithographic process window.
Journal ArticleDOI
Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management
Claudia Arndt,Ralf Bergmann,Franziska Striese,Keresztély Merkel,Domokos Máthé,Liliana R. Loureiro,Nicola Mitwasi,Alexandra Kegler,Frederick Fasslrinner,Karla Elizabeth González Soto,Christin Neuber,Nicole Berndt,Noémi Kovács,Dávid Szöllősi,N. Hegedus,G Toth,Jan-Philipp Emmermann,Kuzhuvelil B. Harikumar,Tibor Kovács,Michael Bachmann,Anja Feldmann +20 more
TL;DR: The favorable pharmacological profile of the anti-PSCA IgG4-TM, and its usage for imaging, targeted alpha therapy, and UniCAR T cell immunotherapy underlines the promising radio-/immunotheranostic capabilities for the diagnostic imaging and treatment of PCa.
Journal ArticleDOI
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Acute Myeloid Leukemia
Marc Cartellieri,Irene Michalk,Malte von Bonin,Thomas Krüger,Slava Stamova,Stefanie Koristka,Claudia Arndt,Anja Feldmann,Marc Schmitz,Martin Wermke,Dirk Lindemann,Martin Bornhäuser,Gerhard Ehninger,Michael Bachmann +13 more
TL;DR: A new method based on a novel CAR-mediated strategy was developed for an efficient in vitro expansion restricted to CAR modified T cells from patients, which efficiently killed AML blasts derived from patients.